BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1752347)

  • 1. Age, sex and ICA influence on beta-cell secretion during the first year after the diagnosis of type 1 diabetes mellitus.
    Montaña E; Fernandez-Castañer M; Rosel P; Gomez J; Soler J
    Diabete Metab; 1991; 17(5):460-8. PubMed ID: 1752347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Islet-cell antibodies: markers of a more severe insulin-dependent diabetes mellitus?
    Montaña E; Goday A; Rosel P; Casamitjana R; Soler J; Gomis R
    Diabetes Res; 1989 Aug; 11(4):167-71. PubMed ID: 2625032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors predicting course of beta-cell function in IDDM.
    Schiffrin A; Suissa S; Weitzner G; Poussier P; Lalla D
    Diabetes Care; 1992 Aug; 15(8):997-1001. PubMed ID: 1505333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Islet cell antibodies (ICA), insulin autoantibodies (IAA), islet cell surface antibodies (ICSA) and C-peptide in 1031 school children in a population with a high background incidence of IDDM.
    Samuelsson U; Ludvigsson J; Sundkvist G
    Diabetes Res Clin Pract; 1994 Dec; 26(3):155-62. PubMed ID: 7736895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships among islet cell antibodies, residual beta-cell function, and metabolic control in patients with insulin-dependent diabetes mellitus of long duration: use of a sensitive C-peptide radioimmunoassay.
    Nakanishi K; Kobayashi T; Miyashita H; Ohkubo M; Sugimoto T; Murase T; Kosaka K; Inouye K; Kono M
    Metabolism; 1990 Sep; 39(9):925-30. PubMed ID: 2202883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.
    Gottsäter A; Landin-Olsson M; Fernlund P; Lernmark A; Sundkvist G
    Diabetes Care; 1993 Jun; 16(6):902-10. PubMed ID: 8325204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketoacidosis at diagnosis is predictive of lower residual beta-cell function and poor metabolic control in type 1 diabetes.
    Fernandez Castañer M; Montaña E; Camps I; Biarnes J; Merino JF; Escriba JM; Nacher V; Rosel P; Soler J
    Diabetes Metab; 1996 Oct; 22(5):349-55. PubMed ID: 8896997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet-cell antibodies and endogenous insulin secretion in Sudanese diabetic children.
    Elamin A; Omer MI; Tuvemo T
    Diabetes Res Clin Pract; 1992 May; 16(2):91-6. PubMed ID: 1600856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry.
    Decochez K; Keymeulen B; Somers G; Dorchy H; De Leeuw IH; Mathieu C; Rottiers R; Winnock F; ver Elst K; Weets I; Kaufman L; Pipeleers DG; Gorus FK;
    Diabetes Care; 2000 Aug; 23(8):1072-8. PubMed ID: 10937500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble CD8 antigen, stimulated C-peptide and islet cell antibodies are predictors of insulin requirement in newly diagnosed patients with unclassifiable diabetes.
    Di Bonito P; De Bellis A; Capaldo B; Turco S; Corigliano G; Pace E; Bizzarro A
    Acta Diabetol; 1996 Sep; 33(3):220-4. PubMed ID: 8904929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of islet cell antibodies during the clinical period of type 1 diabetes. High titres at diagnosis are associated with longer persistence.
    Goday A; Fernandez J; Gonzalez-Clemente JM; Ferrer J; Usach E; Gomis R; Vilardell E
    Diabetes Res; 1991 Aug; 17(4):169-74. PubMed ID: 1823637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.
    Zanone MM; Catalfamo E; Pietropaolo SL; Rabbone I; Sacchetti C; Cerutti F; Trucco M; Cavallo-Perin P
    Metabolism; 2003 Jan; 52(1):25-9. PubMed ID: 12524658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes.
    Williams AJ; Bingley PJ; Moore WP; Gale EA;
    Diabetologia; 2002 Feb; 45(2):217-23. PubMed ID: 11935153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between residual beta-cell function and islet cell antibodies in newly diagnosed type I diabetes. Follow-up study.
    Peig M; Gomis R; Ercilla G; Casamitjana R; Bottazzo GF; Pujol-Borrell R
    Diabetes; 1989 Nov; 38(11):1396-401. PubMed ID: 2695374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM.
    Kobayashi T; Nakanishi K; Murase T; Kosaka K
    Diabetes; 1996 May; 45(5):622-6. PubMed ID: 8621013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Islet cell antibodies, but not glutamic acid decarboxylase antibodies, are decreased by plasmapheresis in patients with newly diagnosed insulin-dependent diabetes mellitus.
    Sundkvist G; Hagopian WA; Landin-Olsson M; Lernmark A; Ohlsson L; Ericsson C; Ahlmén J
    J Clin Endocrinol Metab; 1994 May; 78(5):1159-65. PubMed ID: 8175973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting and patterns of residual insulin secretion during the first year of type 1 (insulin-dependent) diabetes mellitus in children.
    Sochett EB; Daneman D; Clarson C; Ehrlich RM
    Diabetologia; 1987 Jul; 30(7):453-9. PubMed ID: 3311859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predicting residual beta-cell function in the first year after diagnosis of childhood type 1 diabetes.
    Couper JJ; Hudson I; Werther GA; Warne GL; Court JM; Harrison LC
    Diabetes Res Clin Pract; 1991 Jan; 11(1):9-16. PubMed ID: 2019237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An association between complement-fixing cytoplasmic islet cell antibodies and endogenous insulin secretion in children with insulin-dependent diabetes mellitus.
    Mustonen A; Knip M; Akerblom HK
    Diabetes; 1983 Aug; 32(8):743-7. PubMed ID: 6347771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a short prednisone regime at clinical onset of type 1 diabetes.
    Goday A; Pujol-Borrell R; Fernandez J; Casamitjana R; Rios M; Vilardell E; Gomis R
    Diabetes Res Clin Pract; 1993 Apr; 20(1):39-46. PubMed ID: 8344127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.